Daniel Lee Chief Executive Officer, Tissue Regenix Group 00:00:00
Tissue Regenix Group's (AIM:TRX) Danny Lee and David Cocke join Katie to talk about its first half of 2022 performance, which was strong in spite of the Covid hangover on elective surgery.